Verastem (VSTM) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2025)
Powered by 
Analysis
Verastem (VSTM) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 14.05% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.65% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 411.50% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -3.34% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 16.78% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.66% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 19.96% |
| 10 | Verastem | 814.94 Mn | 678.59 Mn | 36.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -45.12% |
| Jun 30, 2025 | -48.19% |
| Mar 31, 2025 | -50.37% |
| Dec 31, 2024 | -46.59% |
| Sep 30, 2024 | -45.43% |
| Jun 30, 2024 | -44.56% |
| Mar 31, 2024 | -46.26% |
| Dec 31, 2023 | -55.36% |
| Sep 30, 2023 | -58.70% |
| Jun 30, 2023 | -63.02% |
| Mar 31, 2023 | -58.48% |
| Dec 31, 2022 | -54.03% |
| Sep 30, 2022 | -51.20% |
| Jun 30, 2022 | -49.16% |
| Mar 31, 2022 | -47.67% |
| Dec 31, 2021 | -46.47% |
| Sep 30, 2021 | -41.68% |
| Jun 30, 2021 | -40.32% |
| Mar 31, 2021 | -30.62% |
| Dec 31, 2020 | -21.53% |